Literature DB >> 27366522

Use of Succinylcholine by Anaesthetists in Turkey: A National Survey.

Dilek Ömür1, Hasan Ali Kiraz2, Hasan Şahin2, Hüseyin Toman2, Berna Uyan2, Serpil Ekin2, Volkan Hancı1.   

Abstract

OBJECTIVE: Although succinylcholine (SCh) has side effects, it is among the most commonly used muscle relaxants for rapid induction because of the faster onset of its effects and short effect duration. However, there is no information regarding the frequency of use of SCh by anaesthetists in Turkey. This study aims to investigate the use of SCh by anaesthetists working in Turkey.
METHODS: A web-based survey form was sent by e-mail to anaesthetists working in Turkey. The form comprised a total of 24 questions.
RESULTS: E-mails were sent to a total of 1882 addresses at two separate times. E-mail replies were received from 433 (23%) anaesthetists. Based on those who responded to the survey, 54.27% anaesthetists routinely used SCh for adult elective cases, 29.33% for paediatric elective cases and 74.13% for emergency cases. In adult elective cases, SCh was most frequently chosen for caesarean section (20.5%), and in paediatric elective and emergency cases, SCh was chosen most frequently because difficult intubation was expected (31.3 and 21.4%, respectively).
CONCLUSION: Our study reveals that SCh is still widely used by anaesthetists in Turkey. Majority of physicians who participated our survey were aware of the side effects; however, they reported using SCh in certain special situations. It is evident that creation of a standard care guide for departments is essential. The first stage of creating a standard care guide is to analyse and document the current application. With this aim, more wide-ranging advanced studies should be completed.

Entities:  

Keywords:  Succinylcholine; neuromuscular blockers; survey

Year:  2015        PMID: 27366522      PMCID: PMC4894233          DOI: 10.5152/TJAR.2015.03708

Source DB:  PubMed          Journal:  Turk J Anaesthesiol Reanim        ISSN: 2149-276X


  37 in total

1.  [Application of muscle relaxants for rapid-sequence induction of anaesthesia].

Authors:  R Hofmockel; G Geldner; C Diefenbach; T Fuchs-Buder; K Ulm; M Blobner
Journal:  Anaesthesist       Date:  2003-06       Impact factor: 1.041

2.  Asystole and bradycardia related to anesthetic induction during ECT: a case report.

Authors:  Mark J Russ; Samuel H Bailine
Journal:  J ECT       Date:  2004-09       Impact factor: 3.635

3.  A national survey of the anesthetic management of tonsillectomy surgery in children.

Authors:  Mark Allford; Velupandian Guruswamy
Journal:  Paediatr Anaesth       Date:  2008-12-18       Impact factor: 2.556

4.  Some aspects of the relationship between chemical constitution and curare-like activity.

Authors:  D BOVET
Journal:  Ann N Y Acad Sci       Date:  1951-10       Impact factor: 5.691

5.  A survey of practice of neuromuscular block in the United States and Europe.

Authors:  Rajinder K Mirakhur
Journal:  Anesth Analg       Date:  2011-02       Impact factor: 5.108

6.  A comparison of rocuronium and lidocaine for the prevention of postoperative myalgia after succinylcholine administration.

Authors:  Dennis Spence; Ramona Domen-Herbert; Elizabeth Boulette; R Lee Olson; Charles Vacchiano; John Maye
Journal:  AANA J       Date:  2002-10

7.  Prevention of succinylcholine-induced fasciculation and myalgia: a meta-analysis of randomized trials.

Authors:  Jan-Uwe Schreiber; Christopher Lysakowski; Thomas Fuchs-Buder; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-10       Impact factor: 7.892

Review 8.  Scandinavian clinical practice guidelines on general anaesthesia for emergency situations.

Authors:  A G Jensen; T Callesen; J S Hagemo; K Hreinsson; V Lund; J Nordmark
Journal:  Acta Anaesthesiol Scand       Date:  2010-09       Impact factor: 2.105

9.  Choice of the muscle relaxant for rapid-sequence induction.

Authors:  H J Sparr
Journal:  Eur J Anaesthesiol Suppl       Date:  2001

Review 10.  Goodbye suxamethonium!

Authors:  C Lee
Journal:  Anaesthesia       Date:  2009-03       Impact factor: 6.955

View more
  1 in total

1.  Supramolecular therapeutics to treat the side effects induced by a depolarizing neuromuscular blocking agent.

Authors:  Xiangjun Zhang; Qian Cheng; Lanlan Li; Liqing Shangguan; Chenwen Li; Shengke Li; Feihe Huang; Jianxiang Zhang; Ruibing Wang
Journal:  Theranostics       Date:  2019-05-18       Impact factor: 11.556

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.